CGEN Competitors & Alternatives
Compare Compugen with similar stocks in the same industry
Biotechnology
CGEN
Main Stock$2.62
Tradestie Score
40
Market Cap
$149.66M
P/E Ratio
7.0
Revenue Growth
1.1%
Analyst Upside
+75.9%
Top Competitors
242 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
DBVT
DBV Technologies S.A.
|
$14.55
|
$275.54M | - | 41 | Compare |
|
ALLO
Allogene Therapeutics, Inc. Common Stock
|
$2.09
|
$275.13M | - | 46 | Compare |
|
VOR
Vor Biopharma Inc. Common Stock
|
$23.36
|
$269.08M | 0.1 | 48 | Compare |
|
ZURA
Zura Bio Limited Class A Ordinary Shares
|
$5.85
|
$262.67M | - | 48 | Compare |
|
KYTX
Kyverna Therapeutics, Inc. Common Stock
|
$8.42
|
$258.18M | - | 41 | Compare |
|
VTYX
Ventyx Biosciences, Inc. Common Stock
|
$14.00
|
$256.71M | - | 51 | Compare |
|
NGNE
Neurogene, Inc. Common Stock
|
$38.63
|
$256.54M | - | 41 | Compare |
|
SLN
Silence Therapeutics Plc American Depository Share
|
$13.27
|
$240.89M | - | 38 | Compare |
|
OABI
OmniAb, Inc. Common Stock
|
$4.33
|
$231.77M | - | 37 | Compare |
|
SGMT
Sagimet Biosciences Inc. Series A Common Stock
|
$10.25
|
$227.00M | - | 35 | Compare |
More CGEN Analysis
Data updated: Aug 24, 2026 | Industry: Biotechnology (SIC 2836)
242 stocks in this industry